NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo a dramatic transformation. From the towering heights of One World Trade Center in Manhattan to the historic arches of the Ness Bridge in Scotland, more than 325 iconic landmarks will be bathed in a specific tri-color palette of teal, green, and pink. This synchronized display marks the 2026 iteration of #LightUpMBC, a global initiative spearheaded by METAvivor Research and Support to bring visibility to a population often left in the shadows of traditional breast cancer advocacy: those living with Stage 4, or metastatic, disease.
While October is traditionally associated with a sea of pink ribbons and messages of early detection, October 13 serves as National Metastatic Breast Cancer (MBC) Awareness Day. For the estimated hundreds of thousands of people living with MBC worldwide, the day is a sobering reminder that while early detection can save lives, it is not a guarantee against the eventual spread of the disease.
Main Facts: The Scope of the 2026 #LightUpMBC Campaign
The #LightUpMBC campaign has grown from a grassroots effort into a massive international operation. In 2026, the campaign will see participation across all 50 U.S. states, spanning 195 cities and 20 countries. The choice of colors—teal, green, and pink—is intentional and symbolic. Teal represents healing and spirituality; green signifies the hope of renewal and the "spring of life"; and pink represents the breast cancer origin of the disease. Together, they form the MBC awareness ribbon, a distinct departure from the universal pink ribbon that many in the Stage 4 community feel does not represent their reality.
The centerpiece of the day’s activities is #LightUpMBC Live, a high-production virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT. This program, hosted by MBC advocate Tami Eagle Bowling and Broadway star Kara Lindsay, aims to bridge the gap between scientific discourse and human storytelling. It will feature live reports from illuminated landmarks, testimonials from patients, and performances by world-class artists, including two-time Tony Award winner Victoria Clark and Broadway’s Dorian Harewood.
Crucially, the campaign is not merely about aesthetics. METAvivor, the organizing non-profit, has pledged that 100% of net proceeds from the campaign and the livestream will be funneled directly into metastatic breast cancer research. Unlike many organizations that focus on prevention and early-stage awareness, METAvivor exclusively funds research for Stage 4, aiming to transition the disease from a terminal diagnosis into a manageable chronic condition.
Chronology: From a Single Bridge to a Global Movement
The history of #LightUpMBC is a testament to the power of individual legacy. The movement traces its origins back to 2017, when the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to light up specifically for metastatic breast cancer.
The inspiration for the campaign was Jessica Moore, a young woman who was diagnosed with MBC at the age of 32 and passed away just four years later at 36. Her dream was modest: she wanted to see one local landmark illuminated in the MBC colors to show the world that Stage 4 patients existed and needed more than just "awareness"—they needed a cure.
Following her passing, her best friend, Laura Inahara, founded the #LightUpMBC campaign to fulfill Jessica’s vision.
- 2017-2019: The campaign began as a regional effort in the Northeast United States, successfully lighting several dozen landmarks and raising initial funds for METAvivor.
- 2020-2022: Despite the challenges of the global pandemic, the campaign pivoted to a virtual format. The "LightUpMBC Live" broadcast was born, allowing the movement to reach a global audience.
- 2023-2025: The number of participating landmarks surged past the 200 mark, with international cities in Europe and Asia joining the cause.
- 2026: The campaign reaches its current record-breaking scale, with over 325 landmarks, including major hubs like the Mactan-Cebu Airport in the Philippines and the Willis Tower in Chicago.
Supporting Data: The Stark Reality of Metastatic Disease
The urgency behind the #LightUpMBC campaign is supported by sobering epidemiological data. Metastatic breast cancer occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to distant organs. The most common sites of metastasis are the bones, liver, lungs, and brain.
According to the National Cancer Institute’s SEER (Surveillance, Epidemiology, and End Results) program, approximately 42,670 people in the United States are projected to die from breast cancer in 2026. This equates to roughly 117 deaths every single day. Notably, nearly all deaths from breast cancer are the result of metastatic disease.
The Funding Disparity
One of the primary drivers of METAvivor’s mission is the historical disparity in research funding. It is estimated that while breast cancer receives billions in global funding, only 2% to 5% of those funds are historically dedicated to researching metastatic disease. The vast majority of resources are allocated toward prevention, early detection, and primary treatment.
For the person already living with Stage 4 cancer, "prevention" is a moot point. Their survival depends entirely on the development of new therapies that can circumvent drug resistance. Statistics show that while some patients are diagnosed "de novo" (Stage 4 from the start), many others—nearly 30% of those diagnosed with early-stage breast cancer—will eventually see their cancer return as metastatic, sometimes decades after their initial "successful" treatment.
Treatment and Longevity
The medical community has made strides, but the "cure" remains elusive. Treatment for MBC is lifelong and grueling. Even when a patient achieves "No Evidence of Disease" (NED) on a scan, they are not considered cured; the cancer is simply dormant or too small to be detected. Eventually, the cancer often finds a way to bypass the current line of therapy, necessitating a switch to a new drug. This "treatment hopping" continues until options are exhausted, which is why the continuous pipeline of research funded by METAvivor is a literal lifeline for patients.
Official Responses: Voices from the Frontlines
The leadership at METAvivor emphasizes that this campaign is as much about community as it is about capital.
Dr. Kelly Shanahan, a physician and the METAvivor Board President, has lived with MBC since 2013. Her perspective is one of both medical expertise and personal endurance. “When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan stated. “My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community.”
Laura Inahara, the founder of the campaign, reflects on the exponential growth of the project. “Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love,” Inahara said. She noted that the campaign has now raised over $2.7 million for critical research since its inception, a figure expected to grow significantly following the 2026 event.
Tami Eagle Bowling, the Campaign Director and a survivor living with MBC for 11 years, highlights the importance of the live broadcast. “We want to meet the people behind the lights. This isn’t just about buildings turning colors; it’s about the stories of the people inside those cities who are fighting for their lives every day.”
Implications: Changing the Narrative of Breast Cancer
The #LightUpMBC campaign represents a significant shift in the sociology of disease advocacy. For decades, the "Pink Ribbon" movement has been criticized by some for "pinkwashing"—using the color pink to market products while glossing over the harsh, often fatal realities of the disease.
By reclaiming October 13 and introducing the teal and green colors, METAvivor is forcing a public conversation about what it means to live with a terminal illness in a culture obsessed with "survivorship" and "cures."
The "Chronic Disease" Goal
The long-term implication of the research funded by this campaign is the potential reclassification of MBC. If research can identify ways to stop the spread of cells or keep them indefinitely dormant, MBC could become a survivable, chronic condition—similar to how HIV/AIDS was transformed from a death sentence in the 1980s to a manageable condition today.
Global Advocacy and Policy
The participation of 20 countries suggests that MBC advocacy is becoming a global policy priority. As landmarks in different time zones light up, it creates a "wave of light" that serves as a global call to action for governments and pharmaceutical companies to prioritize Stage 4 research.
Public Engagement
The campaign also leverages the power of social media to democratize advocacy. By encouraging the public to photograph landmarks and use hashtags like #LightUpMBC and #METAvivor, the organization is building a digital archive of support. This visibility is crucial for patients who often feel isolated by their diagnosis.
As the 2026 campaign approaches, the message from the MBC community is clear: awareness is the first step, but research is the only path to survival. On October 13, the world will not just see pink; it will see the teal and green of a community that refuses to be ignored.
How to Participate:
- Watch: #LightUpMBC Live streams October 13 at 8 p.m. ET on METAvivor’s YouTube and Facebook channels.
- Visit: A full list of participating landmarks and donation links can be found at www.lightupmbc.org.
- Social Media: Share photos of illuminated landmarks using the hashtag #LightUpMBC to join the global conversation.
About the Author
